Lufotrelvir:硼氢化钠/氯化钴还原氰基(300kg规模)

文摘   2024-11-03 08:01   天津  

内酰胺片段25的合成

https://doi.org/10.1021/acs.oprd.2c00375

  • 化合物22和溴乙腈低温条件下反应得到化合物23,还原氰基后关环得到化合物3

  • 化合物3去除Boc得到化合物25

  • 化合物3先和氨气反应得到伯酰胺,再去除Boc,就得到帕罗维德的关键中间体5。


第一步

  • 需要-78度,为了保证光学选择性,典型数据dr大于99

  • Hanessian group的实验结论:LiHMDS拔氢烯醇化的低温和淬灭过程的低温对光学选择性影响很大

  • 本文献提示:溴乙腈的预冷和液面下加入,对于光学选择性也是很关键的。


第二步

  • 两种选择,雷尼镍氢气还原,硼氢化钠/氯化钴还原,碱性直接关环可得化合物3。

  • 文献中给出了300kg批量的实验操作。


实验操作
To a 8000 L glass-lined reactor was charged MeOH (1991kg) and cobalt(II) chloride hexahydrate (275 kg) at 20 °C. The solution was cooled to −5 °C. A solution of 23 in MeOH (1574 kg, (360 kg assay corrected) was charged while keeping the temperature in the range of −15 to 0 °C. 
Sodium borohydride (173 kg) was added to the reaction mixture in portions. After charging about 50% of the sodium borohydride, it was held for 1−3 h, monitored progress (confirming NMT 50% 23 remaining), and resumed charge. The reaction mixture was held at −10 °C for about 6−10 h and monitored for progress until NMT 2% of 23 remained (charged more sodium borohydride (25 kg portion) to reach completion as needed). 
Upon meeting reaction completion criteria, the reaction mixture was warmed to 10−15 °C and held for at least 12 h. The reaction mixture was sampled every 4−6 h until conversion to 3 from 24 indicated NMT 2% of 24 remained.

原料药合成工艺开发
有机合成工艺文献分享和总结;有机合成工艺经验分享和交流;原料药研发的法规指导文件交流
 最新文章